Mechanisms of receptor tyrosine kinase activation in cancer
Receptor tyrosine kinases (RTKs) play an important role in a variety of cellular processes
including growth, motility, differentiation, and metabolism. As such, dysregulation of RTK …
including growth, motility, differentiation, and metabolism. As such, dysregulation of RTK …
[HTML][HTML] Glioblastoma targeted therapy: updated approaches from recent biological insights
Glioblastoma (WHO grade IV astrocytoma) is the most frequent primary brain tumor in adults,
representing a highly heterogeneous group of neoplasms that are among the most …
representing a highly heterogeneous group of neoplasms that are among the most …
[HTML][HTML] Diagnostic and therapeutic biomarkers in glioblastoma: current status and future perspectives
W Szopa, TA Burley, G Kramer-Marek… - BioMed research …, 2017 - hindawi.com
Glioblastoma (GBM) is a primary neuroepithelial tumor of the central nervous system,
characterized by an extremely aggressive clinical phenotype. Patients with GBM have a …
characterized by an extremely aggressive clinical phenotype. Patients with GBM have a …
Paediatric and adult glioblastoma: multiform (epi) genomic culprits emerge
We have extended our understanding of the molecular biology that underlies adult
glioblastoma over many years. By contrast, high-grade gliomas in children and adolescents …
glioblastoma over many years. By contrast, high-grade gliomas in children and adolescents …
Malignant astrocytic glioma: genetics, biology, and paths to treatment
FB Furnari, T Fenton, RM Bachoo… - Genes & …, 2007 - genesdev.cshlp.org
Malignant astrocytic gliomas such as glioblastoma are the most common and lethal
intracranial tumors. These cancers exhibit a relentless malignant progression characterized …
intracranial tumors. These cancers exhibit a relentless malignant progression characterized …
Glioblastoma: from molecular pathology to targeted treatment
TF Cloughesy, WK Cavenee… - Annual review of …, 2014 - annualreviews.org
Glioblastoma (GBM) is one of the most lethal human cancers. Genomic analyses are
defining the molecular architecture of GBM, uncovering relevant subsets of patients whose …
defining the molecular architecture of GBM, uncovering relevant subsets of patients whose …
Understanding high grade glioma: molecular mechanism, therapy and comprehensive management
Y Wang, T Jiang - Cancer letters, 2013 - Elsevier
High-grade gliomas (HGGs) account for the vast majority of all gliomas, including
glioblastoma (World Health Organization (WHO) grade IV) and anaplasticgliomas (WHO …
glioblastoma (World Health Organization (WHO) grade IV) and anaplasticgliomas (WHO …
Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?
S Tanaka, DN Louis, WT Curry, TT Batchelor… - Nature reviews Clinical …, 2013 - nature.com
Glioblastomas are heterogeneous neoplasms that are driven by complex signalling
pathways, and are among the most aggressive and challenging cancers to treat. Despite …
pathways, and are among the most aggressive and challenging cancers to treat. Despite …
The EGFRvIII variant in glioblastoma multiforme
HK Gan, AH Kaye, RB Luwor - Journal of Clinical Neuroscience, 2009 - Elsevier
Glioblastoma multiforme (GBM) is the most common brain tumour and has the worst
prognosis. Epidermal growth factor receptor (EGFR) gene amplification, mutation and re …
prognosis. Epidermal growth factor receptor (EGFR) gene amplification, mutation and re …
EGFR as a clinical marker in glioblastomas and other gliomas
Epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein and a member of
the tyrosine kinase superfamily receptor. Gliomas are tumors originating from glial cells …
the tyrosine kinase superfamily receptor. Gliomas are tumors originating from glial cells …